Written by Jörg Melzer and the CAM-Cancer Consortium.
Updated October 1, 2008

Galavit

Is Galavit safe?

No independent safety evaluation of Galavit has been published. 14 Information given below are statements made by the provider.

Contraindications

Pregnancy, idiosyncrasy against the active substance. 1

Precautions / warnings

None stated.1

Adverse effects

In very rare cases there may be idiosyncratic (allergic) reactions, which will disappear as soon as Galavit is discontinued. 1

Interactions

None are known. 1

Quality issues

There are no independent assessments of the quality of Galavit.

Citation Jörg Melzer, CAM-Cancer Consortium. Galavit [online document]. http://www.cam-cancer.org/CAM-Summaries/Dietary-approaches/Galavit. October 1, 2008.

References

  1. Pharma [homepage on the internet]. 2004 [cited 25.07]. Medisan Pharmaceuticals Ltd. Galavit Documents. Galavit Brochure. Scientific Information. Available from: http://www.galavit.com/
  2. Deutsche-Gesellschaft-für-Hämatologie-und-Onkologie [homepage on the internet]. 2001 [cited 25.07]. Deutsche-Gesellschaft-für Hämatologie-und-Onkologie. Krebstherapie mit Galavit. Available from: http://www.dgho.de/aktuell/galavit.htm
  3. Heber D [homepage on the internet]. 2001 [cited 25.07.2005]. arznei-telegramm. Galavit = Luminol? Available from: http://www.arznei-telegramm.de/zeit/0101c.php3
  4. Anonymous. Galavit gegen Krebs. Russisches 'Wundermittel' aus der Weltraumforschung. Deutsche Apotherkerzeitung 2000; 140: 51-52.
  5. Winter D. Galavit. In: Münstedt K, editor. Ratgeber unkonventionelle Krebstherapien. Landsberg: ecomed Medizin; 2005. p. 247-249.
  6. Buerger-Forum [homepage on the internet]. 2001 [cited 25.07.]. Galavit: zwielichtige Geschäfte, gefährliche Experimente. Available from: http://www.verbrauchernews.de/artikel/0000007183.html
  7. Galavit. In: Josef B, editor. Grundlagen der Komplementäronkologie. Theorie und Praxis. Stuttgart: Hippokrates; 2002. p. 300-301.
  8. Irmey G, Jordan A-L, Norton R. 110 wirksame Behandlungsmöglichkeiten bei Krebs. Heidelberg: Haug; 2001.
  9. Arzneimittelkommission-der-deutschen-Ärzteschaft. Zur Anwendung des Präparates "Galavit" in der Krebstherapie. Dtsch Arztebl 2001; 98: A 1016.
  10. SKAK [homepage on the internet]. 2001 [cited 10.11.2005]. Krebsliga Schweiz. Galavit "Krebsimmuntherapie". Available from: http://www.swisscancer.ch/dt_fr/content/orange/pdf/skak/01_03_galavit_d.pdf
  11. Nelyubov MV. Cytokins in the pathogenesis of astrakhan spotted fever and North Asian scrub typhus: problems of immunocorrection. Bull Exp Biol Med 2002; 134: 165-7.
  12. Larina TV, Bondarenko AV, Bogomolova NS, Vinnitsky LI, Bunyatyan KA, Nikoda VV. [The immune status and its correction in patients after reconstructive surgeries for cicatricial stenosis of trachea]. Anesteziol Reanimatol 2004: 83-5.
  13. Maev IV, Kaziulin AN, Kucheriavyi Iu A, Gadzhieva MG. [Microcirculatory disorders in chronic erosions of the stomach]. Klin Med (Mosk) 2003; 81: 37-42
  14. Jellin J, Gregory P, Batz F, Hitchens K. Pharmacist's letter / prescriber's letter natural medicines comprehensive database
Legal notice
The present documentation has been compiled by the CAM-CANCER Project with all due care and expert knowledge. However, the CAM-CANCER Project provides no assurance, guarantee or promise with regard to the correctness, accuracy, up-to-date status or completeness of the information it contains. This information is designed for health professionals. Readers are strongly advised to discuss the information with their physician. Accordingly, the CAM-CANCER Project shall not be liable for damage or loss caused because anyone relies on the information.